Update on seeking United States FDA approval & market entry
Filed with ASX · · 1 page · English
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Appointment of new non-executive director
- OIL March 2021 Quarterly Report and Appendix 4C
- Appointment of new non-executive chair
- Appendix 4D and Financial Statements - 31 December 2020
- OIL breast cancer study to commence next stage - revised
Later from Optiscan Imaging
- OIL June 2021 Quarterly Report and Appendix 4C
- Appendix 4E and 2021 Annual Report
- OIL FY21 Annual Results Presentation
- Receipt of R&D Tax Incentive Rebate
- OIL September 2021 Quarterly Report and Appendix 4C
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging